Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment.

Q1 Medicine Ontario Health Technology Assessment Series Pub Date : 2019-02-19 eCollection Date: 2019-01-01
{"title":"Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People with chronic venous insufficiency who develop leg ulcers face a difficult condition to treat. Venous leg ulcers may persist for long periods of time and have a negative impact on quality of life. Treatment requires frequent health care provider visits, creating a substantial burden across health care settings.The objective of this health technology assessment was to evaluate the effectiveness, safety, cost-effectiveness, budget impact, and patient experiences of compression stockings for prevention of venous leg ulcer recurrence.</p><p><strong>Methods: </strong>We conducted a systematic review of the literature to identify randomized trials and observational studies examining the effectiveness of compression stockings in reducing the risk of recurrence of venous leg ulcers after healing and/or reported on the quality of life for patients and any adverse events from the wearing of compression stockings. We performed a literature search to identify studies and evaluated the quality of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.We conducted a cost-utility analysis with a 5-year time horizon from the perspective of the Ontario Ministry of Health and Long-Term Care. We compared compression stockings to usual care (no compression stockings) and simulated a hypothetical cohort of 65-year-old patients with healed venous ulcers, using a Markov model. Model input parameters were obtained primarily from the published literature. In addition, we used Ontario costing sources and consultation with clinical experts. We estimated quality-adjusted life years gained and direct medical costs. We conducted sensitivity analyses and a budget impact analysis to estimate the additional costs required to publicly fund compression stockings in Ontario. All costs are presented in 2018 Canadian dollars.We spoke to people who recently began using compression stockings and those who have used them for many years to gain an understanding of their day-to-day experience with the management of chronic venous insufficiency and compression stockings.</p><p><strong>Results: </strong>One randomized controlled trial reported that the recurrence rate was significantly lower at 12 months in people who were assigned to the compression stocking group compared with people assigned to the control group (risk ratio 0.43, 95% CI, 0.27-0.69; <i>P</i> = .001) (GRADE: Moderate). Three randomized controlled trials reported no significant difference in recurrence rates between the levels of pressure. One randomized controlled trial also reported that the risk of recurrence was six times higher in those who did not adhere to compression stockings than in those who did adhere. One single-arm cohort study showed that the recurrence rate was considerably higher in people who did not adhere or had poor adherence (79%) compared with those who adhered to compression stockings (4%).Compared with usual care, compression stockings were associated with higher costs and with increased quality-adjusted life years. We estimated that, on average, the incremental cost-effectiveness ratio of compression stockings was $27,300 per quality-adjusted life year gained compared to no compression stockings. There was some uncertainty in our results, but most simulations (> 70%) showed that the incremental cost-effectiveness ratio remained below $50,000 per quality-adjusted life-year. We estimated that the annual budget impact of funding compression stockings would range between $0.95 million and $3.19 million per year over the next five years.People interviewed commonly reported that chronic venous insufficiency had a substantial impact on their day-to-day lives. There were social impacts from the difficulty or inability to walk and emotional impacts from the loss of independence and fear of ulcer recurrence. There were barriers to the wearing of compression stockings, including replacement cost and the difficulty of putting them on; however, most people interviewed reported that using compression stockings improved their condition and their quality of life.</p><p><strong>Conclusions: </strong>The available evidence shows that, compared with usual care, compression stockings are effective in preventing venous leg ulcer recurrence and likely to be cost-effective. In people with a healed venous leg ulcer, wearing compression stockings helps to reduce the risk of recurrence by about half. Publicly funding compression stockings for people with venous leg ulcers would result in additional costs to the Ontario health care system over the next 5 years. Despite concerns about cost and the daily chore of wearing compression stockings, most people interviewed felt that compression stockings provided important benefits through reduction of swelling and prevention of recurrence.</p>","PeriodicalId":39160,"journal":{"name":"Ontario Health Technology Assessment Series","volume":"19 2","pages":"1-86"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394515/pdf/ohtas-19-1.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ontario Health Technology Assessment Series","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: People with chronic venous insufficiency who develop leg ulcers face a difficult condition to treat. Venous leg ulcers may persist for long periods of time and have a negative impact on quality of life. Treatment requires frequent health care provider visits, creating a substantial burden across health care settings.The objective of this health technology assessment was to evaluate the effectiveness, safety, cost-effectiveness, budget impact, and patient experiences of compression stockings for prevention of venous leg ulcer recurrence.

Methods: We conducted a systematic review of the literature to identify randomized trials and observational studies examining the effectiveness of compression stockings in reducing the risk of recurrence of venous leg ulcers after healing and/or reported on the quality of life for patients and any adverse events from the wearing of compression stockings. We performed a literature search to identify studies and evaluated the quality of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.We conducted a cost-utility analysis with a 5-year time horizon from the perspective of the Ontario Ministry of Health and Long-Term Care. We compared compression stockings to usual care (no compression stockings) and simulated a hypothetical cohort of 65-year-old patients with healed venous ulcers, using a Markov model. Model input parameters were obtained primarily from the published literature. In addition, we used Ontario costing sources and consultation with clinical experts. We estimated quality-adjusted life years gained and direct medical costs. We conducted sensitivity analyses and a budget impact analysis to estimate the additional costs required to publicly fund compression stockings in Ontario. All costs are presented in 2018 Canadian dollars.We spoke to people who recently began using compression stockings and those who have used them for many years to gain an understanding of their day-to-day experience with the management of chronic venous insufficiency and compression stockings.

Results: One randomized controlled trial reported that the recurrence rate was significantly lower at 12 months in people who were assigned to the compression stocking group compared with people assigned to the control group (risk ratio 0.43, 95% CI, 0.27-0.69; P = .001) (GRADE: Moderate). Three randomized controlled trials reported no significant difference in recurrence rates between the levels of pressure. One randomized controlled trial also reported that the risk of recurrence was six times higher in those who did not adhere to compression stockings than in those who did adhere. One single-arm cohort study showed that the recurrence rate was considerably higher in people who did not adhere or had poor adherence (79%) compared with those who adhered to compression stockings (4%).Compared with usual care, compression stockings were associated with higher costs and with increased quality-adjusted life years. We estimated that, on average, the incremental cost-effectiveness ratio of compression stockings was $27,300 per quality-adjusted life year gained compared to no compression stockings. There was some uncertainty in our results, but most simulations (> 70%) showed that the incremental cost-effectiveness ratio remained below $50,000 per quality-adjusted life-year. We estimated that the annual budget impact of funding compression stockings would range between $0.95 million and $3.19 million per year over the next five years.People interviewed commonly reported that chronic venous insufficiency had a substantial impact on their day-to-day lives. There were social impacts from the difficulty or inability to walk and emotional impacts from the loss of independence and fear of ulcer recurrence. There were barriers to the wearing of compression stockings, including replacement cost and the difficulty of putting them on; however, most people interviewed reported that using compression stockings improved their condition and their quality of life.

Conclusions: The available evidence shows that, compared with usual care, compression stockings are effective in preventing venous leg ulcer recurrence and likely to be cost-effective. In people with a healed venous leg ulcer, wearing compression stockings helps to reduce the risk of recurrence by about half. Publicly funding compression stockings for people with venous leg ulcers would result in additional costs to the Ontario health care system over the next 5 years. Despite concerns about cost and the daily chore of wearing compression stockings, most people interviewed felt that compression stockings provided important benefits through reduction of swelling and prevention of recurrence.

Abstract Image

Abstract Image

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预防腿部静脉性溃疡复发的压缩袜:一项健康技术评估。
背景:慢性静脉功能不全并发腿部溃疡的患者很难治疗。下肢静脉溃疡可能持续很长一段时间,并对生活质量产生负面影响。治疗需要经常访问卫生保健提供者,这给整个卫生保健机构造成了沉重负担。本卫生技术评估的目的是评估加压袜预防腿部静脉性溃疡复发的有效性、安全性、成本效益、预算影响和患者体验。方法:我们对文献进行了系统的回顾,以确定随机试验和观察性研究,以检查压缩袜在降低静脉性腿部溃疡愈合后复发的风险和/或报告患者的生活质量和穿着压缩袜的任何不良事件的有效性。我们进行了文献检索,以确定研究,并使用分级推荐评估、发展和评价(GRADE)方法评估证据的质量。我们从安大略省卫生和长期护理部的角度进行了5年的成本效用分析。我们比较了加压袜和常规护理(不加加压袜),并使用马尔可夫模型模拟了一组65岁静脉溃疡愈合的患者。模型输入参数主要来源于已发表的文献。此外,我们使用安大略省的成本计算资源并咨询临床专家。我们估计了获得的质量调整生命年和直接医疗费用。我们进行了敏感性分析和预算影响分析,以估计安大略省公共资助压缩袜所需的额外成本。所有费用均以2018年加元计算。我们采访了最近开始使用压缩袜的人,以及那些使用了多年的人,以了解他们管理慢性静脉功能不全和压缩袜的日常经验。结果:一项随机对照试验报告,与对照组相比,被分配到压缩袜组的患者在12个月时的复发率显著降低(风险比0.43,95% CI, 0.27-0.69;P = .001) (GRADE: Moderate)。三个随机对照试验报告不同血压水平的复发率无显著差异。一项随机对照试验也报告说,没有坚持穿紧身衣的患者复发的风险比坚持穿紧身衣的患者高6倍。一项单臂队列研究显示,与坚持穿压缩袜的患者(4%)相比,未坚持或依从性差的患者(79%)的复发率要高得多。与常规护理相比,压缩长袜与更高的成本和更高的质量调整寿命年有关。我们估计,平均而言,与不使用压缩袜相比,每增加质量调整寿命年,压缩袜的增量成本效益比为27,300美元。我们的结果有一些不确定性,但大多数模拟(> 70%)表明,每个质量调整生命年的增量成本效益比仍低于50,000美元。我们估计,在未来五年内,资助压缩袜的年度预算影响将在每年95万至319万美元之间。受访者普遍表示,慢性静脉功能不全对他们的日常生活有重大影响。行走困难或无法行走对社会有影响,失去独立性和害怕溃疡复发对情绪有影响。穿压缩袜有一些障碍,包括更换成本和穿起来的困难;然而,大多数接受采访的人报告说,使用压缩袜改善了他们的状况和生活质量。结论:现有证据表明,与常规护理相比,加压袜在预防静脉性腿部溃疡复发方面是有效的,并且可能具有成本效益。对于腿部静脉性溃疡愈合的人,穿紧身衣有助于减少复发的风险约一半。在接下来的5年里,为患有静脉性腿部溃疡的人提供压缩袜的公共资金将导致安大略省卫生保健系统的额外费用。尽管担心穿着压缩袜的成本和日常琐事,但大多数受访者认为压缩袜通过减少肿胀和预防复发提供了重要的好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ontario Health Technology Assessment Series
Ontario Health Technology Assessment Series Medicine-Medicine (miscellaneous)
CiteScore
4.60
自引率
0.00%
发文量
0
期刊最新文献
Level 2 Polysomnography for the Diagnosis of Sleep Disorders: A Health Technology Assessment. Pelvic Floor Muscle Training for Stress Urinary Incontinence, Fecal Incontinence, and Pelvic Organ Prolapse: A Health Technology Assessment. Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment. Sucrose Octasulfate-Impregnated Dressings for Adults With Difficult-to-Heal Noninfected Diabetic Foot Ulcers and Difficult-to-Heal Noninfected Venous Leg Ulcers: A Health Technology Assessment. Robotic-Assisted Surgery for Rectal Cancer: An Expedited Summary of the Clinical Evidence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1